We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RICHTER:BETChemical Works of Gedeon Richter Plc Analysis

Data as of 2026-06-22 - not real-time

$31.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock has slipped sharply below recent support, with the short‑term moving average now beneath the market price and the mid‑range RSI indicating neutral momentum. The MACD histogram is negative, signalling bearish pressure, while overall trend metrics suggest a neutral stance amid rising volume.
Fundamental backdrop: Valuation metrics are compelling, with the price‑earnings multiple far under the industry norm and a price‑to‑book ratio that points to deep discounting. The dividend yield is attractive and the payout ratio sits comfortably within cash‑flow capacity, supporting sustainability. Low beta and a defensive healthcare focus temper volatility, though recent price action and high short‑term volatility elevate risk. Material news highlights continued community engagement through the journalism award, but no direct catalyst affecting earnings or pipeline is evident.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price trading below recent support
  • bearish MACD momentum
  • elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation discount to peers
  • strong dividend yield with sustainable payout
  • low beta indicating defensive profile

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • stable demand in specialty and generic pharmaceuticals
  • strategic collaborations expanding pipeline
  • consistent cash generation supporting dividend and growth

Key Metrics & Analysis

Financial Health

Revenue Growth-1.70%
Profit Margin24.80%
P/E Ratio7.4
ROE16.36%
ROA11.03%
Debt/Equity6.86
P/B Ratio0.0
Free Cash Flow$193.1B
Industry P/E24.1

Technical Analysis

TrendNeutral
RSI44.1
Support$37.30
Resistance$43.62
MA 20$39.52
MA 50$40.76
MA 200$33.06
MACDBearish
VolumeIncreasing
Fear & Greed Index91.75

Valuation

Fair Value$13,935.70
GradeUndervalued
TypeValue
Dividend Yield5.50%

Risk Assessment

Beta0.66
Volatility40.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.